LOMBARD ODIER ASSET MANAGEMENT (SWITZERLAND) SA Halozyme Therapeutics, Inc. Transaction History

LOMBARD ODIER ASSET MANAGEMENT (SWITZERLAND) SA portfolio value:

$15.68M
portfolio value

LOMBARD ODIER ASSET MANAGEMENT (SWITZERLAND) SA quarter portfolio value change:

-10.14%
quarter

Halozyme Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -5.88% -24.78K shares -2.86M $39.54 396.61K
Q2 2022 share Decrease -31.38% -192.68K shares -5.94M $44 421.40K
Q1 2022 share Increase 0.00% 614.09K shares 24.49M $39.88 614.09K
Q3 2021 share Decrease -100.00% -300K shares -13.62M $40.68 0
Q2 2021 share Decrease -33.33% -150K shares -5.13M $45.41 300K
Q1 2021 share Decrease -4.26% -20K shares -1.31M $41.69 450K
Q4 2020 share Decrease -14.55% -80K shares 5.62M $42.71 470K
Q3 2020 share Decrease -12.70% -80K shares -2.43M $26.28 550K
Q2 2020 share Decrease -30.00% -270K shares 699K $26.81 630K
Q1 2020 share 0.00% 0 shares 234K $17.99 900K
Q4 2019 share Increase +200.00% 600K shares 11.30M $17.73 900K
Q3 2019 share Decrease -45.45% -250K shares -4.79M $15.51 300K
Q2 2019 share Increase 0.00% 550K shares 9.44M $17.18 550K
Q4 2018 share Decrease -100.00% -500K shares -9.08M $14.63 0
Q3 2018 share Increase 0.00% 500K shares 9.08M $18.17 500K
Q1 2018 share Decrease -100.00% -324.5K shares -6.57M $19.59 0
Q4 2017 share Increase +62.25% 124.5K shares 3.1M $20.26 324.5K
Q3 2017 share Increase +44.12% 61.22K shares 1.69M $17.37 200K
Q2 2017 share Decrease -53.74% -161.22K shares -2.10M $12.82 138.77K
Q1 2017 share Decrease -16.67% -60K shares 331K $12.96 300K
Q4 2016 share Increase +80.00% 160K shares 1.16M $9.88 360K
Q3 2016 share Increase 0.00% 200K shares 2.38M $12.08 200K
Q1 2016 share Decrease -100.00% -480K shares -8.31M $9.47 0